ClinicalTrials.gg
Sign In

Adenocarcinoma, Follicular clinical trials

The registry lists 66 studies for Adenocarcinoma, Follicular across more than 10 countries. 8 are recruiting or about to start. 13 of them are mainly about Adenocarcinoma, Follicular (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Adenocarcinoma, Follicular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Active, not recruiting
8
Terminated
6
Recruiting
6
Status unknown
4
Not yet recruiting
2

Phase

Phase 2
35
Phase 1
12
Phase 3
4

Where

United States
45
Canada
4
France
4
Germany
4
Netherlands
3
Italy
3

Who runs them

National Cancer Institute (NCI) (16) · Mayo Clinic (3) · Exelixis (2) · National Taiwan University Hospital (2) · Massachusetts General Hospital (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · University College, London (2) · European Organisation for Research and Treatment of Cancer - EORTC (2)

What is being tested here

Drugs under test in Adenocarcinoma, Follicular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Zanzalintinib101
Cobimetinib101
Vemurafenib101
Selpercatinib101
Iodine I-131101
Cabozantinib015
Lenvatinib003
Sunitinib003
Thyrotropin Alfa022
Sorafenib002

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Angiogenesis inhibitors 5 · Immune checkpoint inhibitors 3

Coming up

3phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 6 Adenocarcinoma, Follicular studies recruiting now, 5 (83%) set no upper age limit and 0 (0%) stop at 75 or younger. 3 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
102 (33%)2 (33%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
756 (100%)6 (100%)
856 (100%)6 (100%)

Across all 66 studies, recruiting or not: 6% stop at 75 or younger and 6% at 65; 17% take children; 0% are for women only and 2% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 66. Browse all 66 → or search them.